Fetalix participated in the EIT Health InnoStars Grand Final, an event that brings together some of Europe’s most promising healthcare and biotech startups to showcase innovation and connect with key stakeholders across the innovation landscape.
The EIT Health InnoStars programme supports high-potential startups in validating and accelerating their technologies through structured mentoring, training, and exposure to healthcare innovation networks. Participation in its Grand Final reflects recognition within this ecosystem and contributes to strengthening a company’s visibility and strategic positioning.
During the event, Fetalix presented its vision for regenerative biotechnology and its approach to addressing intervertebral disc degeneration and low back pain through biomaterial-based solutions. The participation also provided an opportunity to engage with peers, industry experts, and potential collaborators within the European deep-tech ecosystem.
This milestone reflects Fetalix’s continued integration into the European innovation landscape.
November 27, 2024
